BioCentury | Jul 29, 2020
Finance

Data Bytes: Top investors behind preclinical IPOs

Crossover investors are the most prolific backers of venture rounds for companies that have gone public on NASDAQ before entering the clinic. They account for about half of the most frequent investors, according to a...
Items per page:
1 - 1 of 1
BioCentury | Jul 29, 2020
Finance

Data Bytes: Top investors behind preclinical IPOs

Crossover investors are the most prolific backers of venture rounds for companies that have gone public on NASDAQ before entering the clinic. They account for about half of the most frequent investors, according to a...
Items per page:
1 - 1 of 1